Gene · 488
Papers3,333
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
21 to 40 of 3,333
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Activation of sarco/endoplasmic reticulum Ca²⁺-ATPase 2 (SERCA2) reduces brain injury and improves cognitive function following ischemic stroke. | Biomed Pharmacother | 2026 | 42161231 | PubTator, text mining | PubMed |
| The SERCA Pump: A Key Molecular Target in Calcium Handling of Vascular Smooth Muscle Cells in Metabolic Syndrome. | Handb Exp Pharmacol | 2026 | 42113224 | PubTator, text mining | PubMed |
| Segmental Darier's disease along blaschko's line: Unique presentation. | Med J Armed Forces India | 2026 | 42111872 | PubTator, text mining | PubMed |
| Caveolin-1 Stabilizes SERCA2 to Counteract Acute Kidney Injury via Suppression of Ca2+-Dependent Endoplasmic Reticulum Stress in Distal Tubules. | Adv Sci (Weinh) | 2026 | 42102380 | PubTator, text mining | PubMed |
| Mephedrene-Induced Cardiac Electrophysiological and Molecular Alterations: An Integrated In Vitro and In Vivo Study. | J Appl Toxicol | 2026 | 42063362 | PubTator, text mining | PubMed |
| Polydopamine nanoparticles reprogram macrophage polarization via SERCA2-associated calcium remodeling to support osteogenic differentiation under inflammatory conditions. | Int Immunopharmacol | 2026 | 42044576 | PubTator, text mining | PubMed |
| From calcium pump to metabolic hub: emerging genetic phenotypes and metabolic networks of SERCA2 in skeletal muscle. | Front Physiol | 2026 | 41940033 | PubTator, text mining | PubMed |
| UPR/ATF4/Noxa pathway overactivation through SERCA2 inhibition or ONC201 treatment combined with ABT-737 triggers apoptosis in chemoresistant ovarian cancer cells and patient-derived tumor organoids. | Cell Death Dis | 2026 | 41896216 | PubTator, text mining | PubMed |
| Genetic Variants Associated with Life Expectancy in Patients with Chagas Disease. | Med Sci (Basel) | 2026 | 41892852 | PubTator, text mining | PubMed |
| ORMDL3: from an asthma susceptibility gene to multi-disease associations. | Front Genet | 2026 | 41884618 | PubTator, text mining | PubMed |
| Investigating PKD2 deficiency-associated cardiomyopathies using hESC-cardiomyocytes and bioengineered 3D ventricular cardiac tissue strips. | Cell Death Dis | 2026 | 41876456 | PubTator, text mining | PubMed |
| Human 3D Cardiac Microtissue Model to Investigate Aldosterone-Induced Fibrosis and Electrical Dysfunction. | Hypertension | 2026 | 41834728 | PubTator, text mining | PubMed |
| Advances in calcium signalling research for the diagnosis and treatment of depression. | Ann Med | 2026 | 41787814 | PubTator, text mining | PubMed |
| Antibody-drug conjugates in colorectal cancer: advances in targeted delivery and personalized oncology. | Front Bioeng Biotechnol | 2026 | 41768137 | PubTator, text mining | PubMed |
| Macroscopic to Ultrastructural Analyses Identify the Loss of Myofibrils as the Primary Mediator of Muscle Fiber Atrophy in Aging and Disuse. | bioRxiv | 2026 | 41757020 | PubTator, text mining | PubMed |
| An Exploratory Biomarker Study of First-Trimester Circulating miRNAs Associated with Later Gestational Diabetes Mellitus. | Int J Mol Sci | 2026 | 41752058 | PubTator, text mining | PubMed |
| Redox Imbalance and Genetic Mutations in Heart Failure: Synergistic Mechanisms and Therapeutic Strategies. | Genes (Basel) | 2026 | 41751609 | PubTator, text mining | PubMed |
| Gene Therapy for Heart Failure: Impact on Mitochondrial Dysfunction. | Biomedicines | 2026 | 41751243 | PubTator, text mining | PubMed |
| The Landscape of SERCA2 in Cardiovascular Diseases: Expression Regulation, Therapeutic Applications, and Emerging Roles. | Biomolecules | 2026 | 41750316 | PubTator, text mining | PubMed |
| Expanding the spectrum of Darier Disease variants: 13 novel ATP2A2 genetic variations discovered in an Italian retrospective analysis. | Gene | 2026 | 41747876 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/488/papers?page=2